We wish to inform you that the Board of Directors of the Company considered and approved the extension of closing date of the ongoing right issue. The issue has been extended to February ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Dr Lalchandani Labs Limited approved extending the closing date of its ongoing Rights Issue by 7 days, from Friday, February 20, 2026 to Friday, February 27, 2026. The Rights Issue had originally opened on February 04, 2026. On-market renunciation of Rights Entitlements was also extended from February 17, 2026 to February 24, 2026. The company said the extension is to allow better participation from eligible shareholders and to give them adequate time to subscribe. As a result, the Basis of Allotment and Date of Allotment have been pushed to March 02, 2026, with credit on March 04 and listing on March 05, 2026. No other changes have been made to the Letter of Offer or related documents.
For existing shareholders, this means they get an extra week to subscribe to their Rights Entitlements if they wish to participate in the issue; the change also pushes the allotment and listing timeline by about a week. The delay could suggest the company is seeking stronger subscription, but no price or discount terms were disclosed in this filing.